Perspective · 30 Dec 2025
Conference abstractPublished 7 Dec 2017
Biomarkers and liver cancer process
Charles University, Czech Republic
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The use of biomarkers in primary liver cancer and metastatic cancer will be presented. Both diagnoses have improved in prognosis and overall survival. The early diagnostics and the aggressiveness estimation have been essential for the successful surgical therapy. But both processes may require the individual and different approaches and regarding to the primary liver cancer it seems to be important to identify the risk group of patients to involve in screening programs. Metastatic liver process will require the optimal follow-up proposal particularly in colorectal and breast cancer in order to make a good decision to perform the surgery resection instead of palliative therapy (Radiofrequency ablation RFA) or chemotherapy. It was confirmed that biomarkers combination of AFP and CA19-9 is appropriate for primary hepatocellular carcinoma diagnosis, in some cases using also cytokeratins, but CEA assessment provided no more benefits. PIVKA and some new procollagens seem to be challenging for this diagnostic process and no biomarkers for routine practice in metastatic liver carcinoma have been performed so far. Based on our long term systematic monitoring we can conclude that using biomarkers seems to be beneficial both for diagnostics and prognosis estimation. The highest sensitivity was achieved for cytokeratins (up to 88%), CEA (around 70%) and very low sensitivity was found for CA 19-9. AFP was not commonly elevated and it seems to be useless to assess it. Biomarkers assessment means for the patient: early diagnostics of cancer project; imaging techniques reduction; prognosis estimation and optimal proposal for therapy procedure and optimal follow-up an optimal complex of biomarkers monitored.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Proteomics & Bioinformatics.
Commentary · 30 Dec 2025
Machine Learning in Bioinformatics Transforming Biological Data into Predictive Insights
Perspective · 30 Dec 2025
Post-Translational Modifications as Dynamic Regulators of Proteome Complexity and Cellular Function
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Proteomics & Bioinformatics
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Topolcan Ondrej”

